Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma

Clinical trial NCT00433537 · COMPLETED

Trial details

NCT number: NCT00433537
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Contiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Stage I Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma

Start date: 2007-05-01
Primary completion: 2013-06-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.